SMTL ID : 4zyf.1

Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with NVP-CGM097

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.80 Å
Oligo State
monomer
Ligands
1 x 4T4: (S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one(Non-covalent)
1 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Holzer, P. et al., Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. J.Med.Chem. (2015)
Release Date
2015-07-29
Peptides
E3 ubiquitin-protein ligase Mdm2: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence

1t4e.1 | 3jzk.1 | 4ere.1 | 4ere.2 | 4erf.1 | 4erf.2 | 4erf.3 | 4oas.1 | 4oas.2 | 4oas.3 | 4oba.1 | 4oba.2 | 4oba.3 | 4occ.1 | 4occ.2 | 4occ.3 | 4qo4.1 | 4qoc.1 | 4qoc.2 | 4qoc.3 | 4qoc.4 | 4qoc.5 | 4qoc.6 | 4zyi.1 | 5ln2.1 | 5oc8.1 | 6ggn.1 | 6q96.1 | 6q96.2 | 6q9h.1  more...